What is ipamorelin?
Ipamorelin mimics ghrelin at the growth hormone secretagogue receptor — a selective nudge that asks the pituitary for a growth-hormone pulse without meaningfully raising cortisol or appetite. That selectivity is why it's so often studied in combination with CJC-1295 or tesamorelin.
These articles explain the mechanism, the combinations, and the evidence in plain language. Like everything Promise offers, it's prescription-only, and a licensed provider makes the call. If you're weighing it against sermorelin or tesamorelin, the comparison articles are the place to start.
15 articles on this topic
-
CJC-1295 Ipamorelin for Women: Evidence and Limits
CJC-1295 with ipamorelin may stimulate the growth-hormone axis, but no clinical trial has tested the combination specifically in women. Perimenopause, estrogen route and the limits of body-composition and sleep evidence all matter to the prescribing decision.
-
Does CJC-1295 Ipamorelin Work? Evidence Review
The combination has no clinical trial of its own. Separate studies show that CJC-1295 and ipamorelin can raise growth hormone signals, but they do not establish predictable sleep, recovery, muscle, or fat-loss results from the blend.
-
Tesamorelin vs CJC-1295: Evidence and Differences
Both peptides signal through the GHRH receptor, but their structures, duration and human evidence differ sharply. The clearest distinction is phase 3 visceral-fat data for tesamorelin versus biomarker studies for CJC-1295.
-
Peptides vs Steroids: What Makes Them Different?
Peptides and anabolic steroids are different molecules with different targets, evidence, risks, and legal status. A peptide is not simply a steroid under a newer name.
-
Tesamorelin vs Ipamorelin: What Sets Them Apart
Both peptides signal the pituitary to release growth hormone, but they use different receptors and carry very different levels of human evidence. Tesamorelin has phase 3 trial data; ipamorelin does not.
-
Peptides for Muscle Growth: Evidence and Limits
Prescription GH-axis peptides can change hormone levels and, in selected patients, body composition. Human evidence does not show that they produce hypertrophy or greater strength in healthy trained adults.
-
Best HGH Peptides: A Best-Fit Comparison
The best HGH peptides are not a strongest-to-weakest ranking. The useful comparison is which receptor they use, how long they act, and whether the evidence matches the reason a clinician is considering them.
-
CJC-1295 No DAC: What the Label Actually Means
CJC-1295 no DAC is label shorthand for modified GRF 1-29, a short-acting GHRH analog without the albumin-binding feature that makes the DAC form last for days.
-
Ipamorelin Side Effects: What Human Data Shows
Human safety data for ipamorelin are unusually thin. Short-term reports exist, but no published trial tells us how common side effects are with months or years of compounded use.
-
Sermorelin vs Ipamorelin: Two Different Receptors
Sermorelin copies the hypothalamus and clears in about four minutes. Ipamorelin copies ghrelin and lasts roughly two hours. The receptor each one binds explains almost everything else about them.
-
Tesamorelin Ipamorelin: Two Receptors, One Vial
Two peptides, two pituitary receptors, one vial. Each half has a research record of its own; the combination has never been tested as a combination.
-
Sermorelin vs CJC-1295: What Actually Differs
Both signal the pituitary through the GHRH pathway. The practical difference is duration: sermorelin is brief, while DAC-bearing CJC-1295 was engineered to remain active far longer.
-
CJC 1295 Ipamorelin Dosage: What Studies Used
There is no validated combined dose. Human studies used different formulations, routes and objectives, so a prescriber has to identify the exact product, interpret the clinical context and set the schedule.
-
Ipamorelin Benefits, Side Effects, Legal Status
Developed at Novo Nordisk in the late 1990s, ipamorelin is a five-amino-acid peptide that released growth hormone in animal studies without raising cortisol even at more than 200 times its effective dose.
-
CJC-1295 and Ipamorelin: Why They're Paired
One prescription, two receptors: CJC-1295 signals through the GHRH receptor while ipamorelin mimics ghrelin at GHSR-1a — two separate inputs to the same growth-hormone axis.